Floatz logo

ASPARAGINASE

Extranodal NK-T-Cell Lymphoma, Nasal Type

National Cancer Centre, Singaporeprotein_peptidePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

53 Active assets in the Extranodal NK-T-Cell Lymphoma, Nasal Type cohort.

Asset / SponsorPhaseRating
PEGASPARGASE
CStone Pharmaceuticals
Phase 4BBB
DEXAMETHASONE
Mingzhi Zhang
Phase 4BBB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Centre, Singapore
Phase 4BBB
ETOPOSIDE
Tarapeutics Science Inc.
Phase 4BB
Tucidinostat
Ruijin Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

ASPARAGINASE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →